Hilton Head Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Hilton Head Capital Partners's BMY Position: Q2 2026 in Review
Hilton Head Capital Partners reduced its Bristol-Myers Squibb (BMY) stake by 2% in Q2 2026, selling an estimated $4.65K and leaving 3,953 shares worth $228K. The position accounts for 0.11% of the portfolio, ranked #145.
Hilton Head Capital Partners first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $245K in Q1 2026. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Hilton Head Capital Partners held 3,953 shares of Bristol-Myers Squibb worth $228K as of Q2 2026.
- Hilton Head Capital Partners sold 81 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.65K.
- Bristol-Myers Squibb made up 0.11% of Hilton Head Capital Partners's portfolio in Q2 2026, its #145 holding.
- Hilton Head Capital Partners first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- Hilton Head Capital Partners's Bristol-Myers Squibb position peaked at $245K in Q1 2026.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Hilton Head Capital Partners's 13F filing for Q2 2026, filed 27 Jul 2026.